Treatment of Clinical T2N0M0 Esophageal Cancer

Keyphrases

• Esophageal Cancer 100%
• T2N0M0 100%
• Adenocarcinoma 50%
• Resection 50%
• Neoadjuvant Therapy 50%
• Long-term Survival 33%
• Lymph Node Metastasis 33%
• Endoscopic Ultrasound 33%
• Poorly Differentiated Tumors 33%
• Treatment Strategy 16%
• Patient Demographics 16%
• Multivariate Analysis 16%
• Survival Analysis 16%
• 5-year Survival 16%
• Surgical Resection 16%
• Survival Prediction 16%
• Significant Predictors 16%
• Postoperative Mortality 16%
• After Surgery 16%
• Kaplan-Meier 16%
• Esophagectomy 16%
• Cox Regression Model 16%
• Postoperative Outcomes 16%
• Transthoracic Approach 16%
• Optimal Treatment 16%
• Clinical Staging 16%
• Surgery Alone 16%
• Two-field 16%
• Institutional Experience 16%
• Neoadjuvant 16%
• Neoadjuvant Chemoradiotherapy (nCRT) 16%
• Pathological Complete Response 16%
• Chemoradiotherapy 16%
• Lymph Node Dissection 16%
• Background Management 16%
• Perioperative Data 16%
• Understaging 16%
• Staging Accuracy 16%
• Treatment Factors 16%

Medicine and Dentistry

• Esophageal Cancer 100%
• Adenocarcinoma 75%
• Neoadjuvant Therapy 75%
• Diseases 75%
• Long Term Survival 50%
• Lymph Node Metastasis 50%
• Chemoradiotherapy 50%
• Endoscopic Ultrasound 50%
• Tumor 50%
• Patient Population 25%
• Survival Analysis 25%
• Retroperitoneal Lymph Node Dissection 25%
• Esophagectomy 25%
• Predictive Factor 25%
• Surgical Mortality 25%
• Multivariate Analysis 25%
• Cox Regression Model 25%
• Median Follow Up 25%